816 related articles for article (PubMed ID: 17914984)
1. Preventive role of genistein in an experimental non-alcoholic steatohepatitis model.
Yalniz M; Bahcecioglu IH; Kuzu N; Poyrazoglu OK; Bulmus O; Celebi S; Ustundag B; Ozercan IH; Sahin K
J Gastroenterol Hepatol; 2007 Nov; 22(11):2009-14. PubMed ID: 17914984
[TBL] [Abstract][Full Text] [Related]
2. Epigallocatechin gallate attenuates experimental non-alcoholic steatohepatitis induced by high fat diet.
Kuzu N; Bahcecioglu IH; Dagli AF; Ozercan IH; Ustündag B; Sahin K
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e465-70. PubMed ID: 17683497
[TBL] [Abstract][Full Text] [Related]
3. Preventive effects of total flavonoids of Litsea coreana leve on hepatic steatosis in rats fed with high fat diet.
Wang JQ; Li J; Zou YH; Cheng WM; Lu C; Zhang L; Ge JF; Huang C; Jin Y; Lv XW; Hu CM; Liu LP
J Ethnopharmacol; 2009 Jan; 121(1):54-60. PubMed ID: 18977425
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory effect of genistein on non-alcoholic steatohepatitis rats induced by high fat diet and its potential mechanisms.
Ji G; Yang Q; Hao J; Guo L; Chen X; Hu J; Leng L; Jiang Z
Int Immunopharmacol; 2011 Jun; 11(6):762-8. PubMed ID: 21320636
[TBL] [Abstract][Full Text] [Related]
5. Effects of fenofibrate and xuezhikang on high-fat diet-induced non-alcoholic fatty liver disease.
Hong XZ; Li LD; Wu LM
Clin Exp Pharmacol Physiol; 2007; 34(1-2):27-35. PubMed ID: 17201732
[TBL] [Abstract][Full Text] [Related]
6. Effects of N-acetylcysteine on oxidative stress in rats with non-alcoholic steatohepatitis.
Samuhasaneeto S; Thong-Ngam D; Kulaputana O; Patumraj S; Klaikeaw N
J Med Assoc Thai; 2007 Apr; 90(4):788-97. PubMed ID: 17487136
[TBL] [Abstract][Full Text] [Related]
7. [Investigation of oxidative stress and antioxidant defense in patients with hepatitis B virus infection and the effect of interferon-alpha plus lamivudine combination therapy on oxidative stress].
Acar A; Görenek L; Aydin A; Eyigün CP; Eken A; Sayal A; Pahsa A
Mikrobiyol Bul; 2009 Jul; 43(3):411-23. PubMed ID: 19795616
[TBL] [Abstract][Full Text] [Related]
8. Pentoxifylline and melatonin in combination with pioglitazone ameliorate experimental non-alcoholic fatty liver disease.
Zaitone S; Hassan N; El-Orabi N; El-Awady el-S
Eur J Pharmacol; 2011 Jul; 662(1-3):70-7. PubMed ID: 21549113
[TBL] [Abstract][Full Text] [Related]
9. Dynamic expression of hepatic thioredoxin mRNA in rats with non-alcoholic fatty liver disease.
Duan XY; Zhao HP; Fan JG
J Dig Dis; 2010 Apr; 11(2):94-100. PubMed ID: 20402835
[TBL] [Abstract][Full Text] [Related]
10. GdCl3 abates hepatic ischemia-reperfusion injury by inhibiting apoptosis in rats.
Li JY; Gu X; Zhang WH; Jia S; Zhou Y
Hepatobiliary Pancreat Dis Int; 2009 Oct; 8(5):518-23. PubMed ID: 19822496
[TBL] [Abstract][Full Text] [Related]
11. Anti-apoptotic and anti-inflammatory effects of Silybum marianum in treatment of experimental steatohepatitis.
Aghazadeh S; Amini R; Yazdanparast R; Ghaffari SH
Exp Toxicol Pathol; 2011 Sep; 63(6):569-74. PubMed ID: 20471811
[TBL] [Abstract][Full Text] [Related]
12. Acetaminophen-induced toxicity is prevented by beta-D-glucan treatment in mice.
Toklu HZ; Sehirli AO; Velioğlu-Oğünç A; Cetinel S; Sener G
Eur J Pharmacol; 2006 Aug; 543(1-3):133-40. PubMed ID: 16822497
[TBL] [Abstract][Full Text] [Related]
13. Amelioration of steatohepatitis with pentoxifylline in a novel nonalcoholic steatohepatitis model induced by high-fat diet.
Yalniz M; Bahçecioğlu IH; Kuzu N; Celebi S; Ataseven H; Ustündağ B; Ozercan IH; Sahin K
Dig Dis Sci; 2007 Sep; 52(9):2380-6. PubMed ID: 17415655
[TBL] [Abstract][Full Text] [Related]
14. A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet.
Baumgardner JN; Shankar K; Hennings L; Badger TM; Ronis MJ
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G27-38. PubMed ID: 17947452
[TBL] [Abstract][Full Text] [Related]
15. Marked elevation of serum mitochondrion-derived markers in mild models of non-alcoholic steatohepatitis in rats.
Murayama H; Ikemoto M; Nagata A
J Gastroenterol Hepatol; 2009 Feb; 24(2):270-7. PubMed ID: 18823438
[TBL] [Abstract][Full Text] [Related]
16. Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency.
Kirsch R; Clarkson V; Verdonk RC; Marais AD; Shephard EG; Ryffel B; de la M Hall P
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):174-82. PubMed ID: 16706830
[TBL] [Abstract][Full Text] [Related]
17. The treatment with antibody of TNF-alpha reduces the inflammation, necrosis and fibrosis in the non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
Koca SS; Bahcecioglu IH; Poyrazoglu OK; Ozercan IH; Sahin K; Ustundag B
Inflammation; 2008 Apr; 31(2):91-8. PubMed ID: 18066656
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of JNK along with activation of ERK1/2 MAPK pathways improve steatohepatitis among the rats.
Aghazadeh S; Yazdanparast R
Clin Nutr; 2010 Jun; 29(3):381-5. PubMed ID: 19748164
[TBL] [Abstract][Full Text] [Related]
19. Hepatic energy metabolism and the differential protective effects of sevoflurane and isoflurane anesthesia in a rat hepatic ischemia-reperfusion injury model.
Bedirli N; Ofluoglu E; Kerem M; Utebey G; Alper M; Yilmazer D; Bedirli A; Ozlu O; Pasaoglu H
Anesth Analg; 2008 Mar; 106(3):830-7, table of contents. PubMed ID: 18292427
[TBL] [Abstract][Full Text] [Related]
20. Effects of beta-carotene on antioxidant status in rats with chronic alcohol consumption.
Lin WT; Huang CC; Lin TJ; Chen JR; Shieh MJ; Peng HC; Yang SC; Huang CY
Cell Biochem Funct; 2009 Aug; 27(6):344-50. PubMed ID: 19637186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
